Education
About Us
Working with TipRanks
Follow Us
Omnicell (OMCL)
NASDAQ:OMCL
OMCL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$22.66 - $55.75
Previous CloseN/A
Volume97.52K
Average Volume (3M)737.93K
Market Cap
$1.45B
Enterprise Value$1.22B
Total Cash (Recent Filing)$381.68M
Total Debt (Recent Filing)$382.55M
Price to Earnings (P/E)68.9
Beta0.31
Next Earnings
Aug 05, 2025EPS Estimate
0.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.26
Shares Outstanding46,843,605
10 Day Avg. Volume582,321
30 Day Avg. Volume737,933
Financial Highlights & Ratios
PEG Ratio0.56
Price to Book (P/B)0.96
Price to Sales (P/S)0.00
P/FCF Ratio8.66
Enterprise Value/Market Cap0.84
Enterprise Value/Revenue0.28
Enterprise Value/Gross Profit2.58
Enterprise Value/Ebitda5.59
Forecast
1Y Price Target
$40.40Price Target Upside30.87% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Omnicell News
Bulls Say, Bears Say
Bulls Say
Financial GuidanceOmnicell has lifted the low end of its adjusted EBITDA range for FY25 by $20 million, indicating a stronger financial performance outlook.
Product InnovationOmnicell has executed well over the past few quarters utilizing product innovation and an improved demand environment to drive positive product revenue growth.
Stock Repurchase ProgramThe company announced a $75 million share repurchase program, suggesting confidence in the company's stock value.
Bears Say
CFO TransitionVisibility remains challenged with a pending CFO change and still early days in new product growth.
Tariff ImpactThere is a risk that tariffs could revert back to a high rate, which might negatively impact future adjusted EBITDA estimates.
Ownership Overview
2.58% Insiders
32.21% Mutual Funds
15.94% Other Institutional Investors
15.88% Public Companies and Individual Investors
OMCL FAQ
What was Omnicell’s price range in the past 12 months?
Omnicell lowest stock price was $22.66 and its highest was $55.74 in the past 12 months.
What is Omnicell’s market cap?
Omnicell’s market cap is $1.45B.
When is Omnicell’s upcoming earnings report date?
Omnicell’s upcoming earnings report date is Aug 05, 2025 which is in 60 days.
How were Omnicell’s earnings last quarter?
Omnicell released its earnings results on May 06, 2025. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.205 by $0.055.
Is Omnicell overvalued?
According to Wall Street analysts Omnicell’s price is currently Undervalued.
Does Omnicell pay dividends?
Omnicell does not currently pay dividends.
What is Omnicell’s EPS estimate?
Omnicell’s EPS estimate is 0.27.
How many shares outstanding does Omnicell have?
Omnicell has 46,843,605 shares outstanding.
What happened to Omnicell’s price movement after its last earnings report?
Omnicell reported an EPS of $0.26 in its last earnings report, beating expectations of $0.205. Following the earnings report the stock price went down -15.841%.
Which hedge fund is a major shareholder of Omnicell?
Currently, no hedge funds are holding shares in OMCL
Omnicell Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$40.40 (30.87% Upside)
$40.40 (30.87% Upside)
Blogger Sentiment
Bullish
OMCL Sentiment 75%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 157.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $567.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 72.4%
Last 30 Days ▲ 62.4%
Last 30 Days ▲ 62.4%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
2.05%
12-Months-Change
Fundamentals
Return on Equity
1.73%
Trailing 12-Months
Asset Growth
-5.79%
Trailing 12-Months
Company Description
Omnicell
Omnicell, Inc. (OMCL) is a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies. The company operates within the healthcare and technology sectors, focusing on the development and delivery of automated medication dispensing systems, central pharmacy automation solutions, and medication adherence tools. Omnicell's products and services enable healthcare providers to enhance medication safety, increase operational efficiency, and improve patient outcomes.
OMCL Company Deck
OMCL Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presents a mixed picture with strong revenue growth and recurring revenue achievements offset by significant challenges due to tariffs and decreased profitability metrics. The company's strategic pivots towards recurring revenue and customer wins are positive, though the tariff impact is a considerable headwind.Read More>OMCL Stock 12 Month Forecast
Average Price Target
$40.40
▲(30.87%Upside)